Theranostics Health
Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Its technologies utilize Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays to accurately measure drug targets and their signaling pathways within tumor cells. Its technologies are of particular use for companies developing Molecular Targeted Therapies and allow insights into the phospho-activation status of drug targets, their downstream pathways and potential survival mechanisms or pathways within targeted cell populations and are utilized in a translational research manner from preclinical SAR-type studies through to Phase II clinical trials.
Industries
Nr. of Employees
small (1-50)
Theranostics Health
Rockville, Maryland, United States, North America
Products
Reverse Phase Protein Microarray (RPPA) Platform
A proteomic assay platform that quantitatively measures protein and phosphoprotein levels from small biological samples to profile cellular signaling pathways.
Proteomic-Based Diagnostic Assays
Diagnostic tests that directly measure protein biomarkers and signaling pathways to guide personalized treatment decisions and drug development.
Proprietary Tissue Fixative Solutions
Chemical solutions developed to preserve tissue samples at room temperature while maintaining protein, phosphoprotein, and transcriptome integrity for analysis.
Proteomic Research Services for Drug Development
Analytical services using proteomic technologies to evaluate drug activity, selectivity, and mechanism of action in preclinical and clinical studies.
Protein and Antibody Products
A range of protein-specific antibodies and assay kits for research and diagnostic applications targeting viral proteins and enzymatic activities.
Reverse Phase Protein Microarray (RPPA) Platform
A proteomic assay platform that quantitatively measures protein and phosphoprotein levels from small biological samples to profile cellular signaling pathways.
Proteomic-Based Diagnostic Assays
Diagnostic tests that directly measure protein biomarkers and signaling pathways to guide personalized treatment decisions and drug development.
Proprietary Tissue Fixative Solutions
Chemical solutions developed to preserve tissue samples at room temperature while maintaining protein, phosphoprotein, and transcriptome integrity for analysis.
Proteomic Research Services for Drug Development
Analytical services using proteomic technologies to evaluate drug activity, selectivity, and mechanism of action in preclinical and clinical studies.
Protein and Antibody Products
A range of protein-specific antibodies and assay kits for research and diagnostic applications targeting viral proteins and enzymatic activities.